Deprescribing Frameworks: Reducing Medications to Cut Side Effects

Imagine you or someone you care for takes five different pills every morning. Now imagine taking eight, ten, or twelve. That isn't just a daily routine; that is a medical balancing act gone wrong. We call this Polypharmacy, defined as the use of five or more medications simultaneously. It happens more often than you think. In fact, roughly 40% of older adults globally fall into this category, according to recent World Health Organization reports. The problem isn't just the cost; it is the risk. Inappropriate medication combinations contribute to 30% of hospital admissions among adults aged 65 and older. To fix this, healthcare systems are turning to Deprescribing Frameworkssystematic processes designed to stop unnecessary medications.

What Actually Is Deprescribing?

Many people think stopping a medicine is just quitting. It is not. Deprescribing is the systematic process of evaluating whether the harms of a medication outweigh its benefits. It considers your actual physical function, how long you expect to live, and what matters most to you personally. Research from 2015 established this as a formal clinical strategy, moving away from the old idea of "more prescriptions equals better care." Today, it is an active intervention. Dr. Amy Gravely, a leading voice in drug safety, notes that deprescribing requires the same rigour as starting a new therapy. You cannot just throw medicines away. You need a plan.

The goal is simple: reduce Potentially Inappropriate Medications (PIMs)drugs known to cause harm in specific populations. For older adults, these drugs often cause confusion, falls, or stomach bleeding. By using structured frameworks, clinicians can identify which medicines are truly necessary and which are legacy issues-prescribed years ago and never reviewed. This reduces the pill burden and cuts down on nasty side effects without compromising health.

Key Frameworks Doctors Use

How do you decide what to stop? Clinicians rely on proven tools rather than guesswork. These tools provide the evidence base for making tough calls about removing essential-seeming drugs.

• STOPP/START Criteria: One of the most widely used tools, version 3 was published in 2021. It lists specific situations where a drug should probably be stopped (STOPP) and when one should be considered (START).
• Beers Criteria: Maintained by the American Geriatrics Society, this list identifies 34 medications potentially inappropriate for older adults. The 2023 edition updated several warnings regarding pain killers and sedatives.
• Shed-MEDS: A newer framework validated in 2023. It involves reviewing best possible medication history, evaluating necessity, making recommendations, and synthesising the data. Studies showed it reduced medication count significantly without increasing adverse events.
• DIGE Initiative: Used nationally in Canada since 2018, this initiative focuses specifically on guidelines for the elderly.

These are not just wishlists. They are backed by GRADE assessments of recommendation strength. For instance, the guideline for proton-pump inhibitors (PPIs) follows a four-step method. First, you identify suitable patients. Second, assess how strong the original reason for the drug was. Third, taper the dose over four to eight weeks. Finally, monitor if symptoms come back. This step-by-step logic prevents dangerous cold-turkey stops.

Medications Most Often Targeted

You cannot deprescribe everything at once. Current evidence-based guidelines focus heavily on five major classes of drugs. If you manage a home with elderly relatives, looking at these specific types can help spot potential risks during doctor visits.

For example, benzodiazepines are notoriously difficult to stop. A pharmacist named Sarah Chen reported success using algorithms from deprescribing.org. She managed to taper 18 out of 22 patients over six months. Only two experienced mild withdrawal symptoms. That kind of track record proves that structured plans work better than winging it.

The Implementation Reality

In theory, deprescribing sounds great. In practice, it faces serious hurdles. Time is the biggest enemy. A survey of 450 clinicians found that primary care physicians average just 7.2 minutes per patient visit. Comprehensive deprescribing conversations require shared decision-making. That is hard to squeeze into seven minutes.

This is why pharmacists play such a huge role. Interventions led by pharmacists or nurse practitioners reduce medication burden by 1.5 to 2.5 drugs without increasing hospital stays. However, implementation rates in primary care remain below 15%. Why? Because standard electronic health records (EHRs) often lack the prompts needed. Some forward-thinking systems have fixed this. Twelve US healthcare systems implemented algorithm-based prompts that default to not prescribing high-risk meds, forcing doctors to actively override safety protocols to prescribe them.

Financially, it makes sense too. Healthcare systems implementing these protocols generate a return on investment of $3.20 for every dollar spent. This comes from reduced medication costs and fewer emergency room visits. The global market for deprescribing is projected to hit $1.2 billion by 2028, driven by aging populations. By 2030, one in six people globally will be over 65, meaning the demand for safe medication management will skyrocket.

Addressing Patient Concerns

Patients often feel anxious about stopping meds they've taken for years. A qualitative study showed 22% of older adults expressed worry despite knowing their pill count was high. They fear their symptoms will return. This is real. Withdrawing a drug like a sleeping pill or antidepressant must be done with care.

Education is the bridge. Explaining that some symptoms improve after stopping a drug helps. Sometimes, dizziness wasn't caused by age, but by the blood pressure tablet itself. When patients see improvements in energy or memory after stopping one drug, confidence builds. But for those with advanced dementia, doctors must be careful. As Dr. Joseph Teno warns, indiscriminate deprescribing can compromise quality of life if symptom management drugs are removed without alternatives.

Policy Shifts and Future Outlook

The tide is shifting towards mandatory reviews. The American Medical Association released a policy in June 2024 stating physicians should routinely assess the continuing appropriateness of all medications. Furthermore, the Centers for Medicare & Medicaid Services announced in early 2024 that deprescribing metrics will be part of the Merit-Based Incentive Payment System starting in 2026. This means doctors will likely get financial penalties or bonuses based on how well they manage unnecessary medications.

Technology is also catching up. The National Institutes of Health funded projects to develop AI-driven EHR tools. These tools will automatically flag opportunities to stop a drug based on patient data. By 2030, experts predict deprescribing assessments will be as routine as checking blood pressure. Until then, frameworks like STOPP/START and DIGE remain our best compass for navigating the complex world of prescription safety.